Hepatitis C Treatment Getting Cheaper, but Still Big Burden for Patients, Insurance Companies

Rodents pave the way for an eventual hepatitis C vaccine
July 31, 2017
FDA Advisers Endorse Genetically Engineered Immunotherapy For Cancer
August 1, 2017
Show all

Hepatitis C Treatment Getting Cheaper, but Still Big Burden for Patients, Insurance Companies

The price of hepatitis C treatment remains a barrier for some.

The cost of treating hepatitis C has dropped some in the past year or so. But price – drugs can list around 100,000 for a course – is still a barrier and can put a big burden on insurance programs like Medicaid, which has to make tough decisions about who qualifies for the lifesaving drugs.

Regional Appalachian pharmacy chain Fruth got a grant in 2016 from the National Association of Chain Drug Stores to begin offering hepatitis C testing for free. Hepatitis C is a virus spread by contact with infected blood that can cause cancer or severe liver damage if untreated. Blood transfusions that happened before 1992 and unsterile tattoos and piercings also put people at risk for hepatitis C. But by far the largest factor in the disease’s spread is intravenous drug use — drugs like heroin.

“We see this as a problem in the community, this is our community that we serve,” said Jamie Bennett, clinical services leader at Fruth. Bennett is talking about the fact that West Virginia has some of the highest rates of hepatitis C in the nation.

Read full article: Hepatitis C Treatment Getting Cheaper, but Still Big Burden for Patients, Insurance Companies | West Virginia Public Broadcasting

Read Full Article: Hepatitis C Treatment Getting Cheaper, but Still Big Burden for Patients, Insurance Companies | West Virginia Public Broadcasting

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.